{"version":"1.0","provider_name":"Franco-German University","provider_url":"https:\/\/www.dfh-ufa.org\/en","author_name":"fbo_master","author_url":"https:\/\/www.dfh-ufa.org\/en\/author\/fbo_master","title":"From Immunology to Oncology and vice versa - Franco-German University","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"oiIXNQq2No\"><a href=\"https:\/\/www.dfh-ufa.org\/en\/research\/from-immunology-to-oncology-and-vice-versa\">From Immunology to Oncology and vice versa<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.dfh-ufa.org\/en\/research\/from-immunology-to-oncology-and-vice-versa\/embed#?secret=oiIXNQq2No\" width=\"600\" height=\"338\" title=\"&#8220;From Immunology to Oncology and vice versa&#8221; &#8212; Franco-German University\" data-secret=\"oiIXNQq2No\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=new RegExp(\"^https?:$\",\"i\"),l=0;l<n.length;l++)n[l].style.display=\"none\";for(l=0;l<i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=d.createElement(\"a\"),a=d.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n","description":"Das Hauptziel ist es, die lang bestehende klinische und wissenschaftliche Kollaboration zwischen INSERM U768, H\u00f4pital Necker France und der Abteilung f\u00fcr H\u00e4matologie, Onkologie und Immunologie, der Kinderklinik in D\u00fcsseldorf zu st\u00e4rken. Beide Zentren kollaborieren seit 2005 in der Behandlung von Patienten nach Gentherapie, dem Austausch von Postdoktoranden und der Neubeschreibung von Immundefizienzsyndromen. Zuk\u00fcnftig geplant ist [&hellip;]"}